[HTML][HTML] Update on fibroblast growth factor 23 in chronic kidney disease
M Wolf - Kidney international, 2012 - Elsevier
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …
Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease?
P Raggi, A Boulay, S Chasan-Taber, N Amin… - Journal of the American …, 2002 - jacc.org
Objectives: We sought to determine clinical and laboratory correlates of calcification of the
coronary arteries (CAs), aorta and mitral and aortic valves in adult subjects with end-stage …
coronary arteries (CAs), aorta and mitral and aortic valves in adult subjects with end-stage …
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in …
P Greenland, RO Bonow, BH Brundage… - Journal of the American …, 2007 - jacc.org
Summary...... 387 Role of CAC Scoring in Assessment of Symptomatic Patients...... 388
Diagnosis of Coronary Stenosis in Patients With Possible CHD by CAC...... 388 Comparison …
Diagnosis of Coronary Stenosis in Patients With Possible CHD by CAC...... 388 Comparison …
[HTML][HTML] Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow, SK Burke, P Raggi… - Kidney international, 2002 - Elsevier
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis
patients. Background Cardiovascular disease is frequent and severe in patients with end …
patients. Background Cardiovascular disease is frequent and severe in patients with end …
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a …
JL Reynolds, AJ Joannides, JN Skepper… - Journal of the …, 2004 - journals.lww.com
Patients with ESRD have a high circulating calcium (Ca)× phosphate (P) product and
develop extensive vascular calcification that may contribute to their high cardiovascular …
develop extensive vascular calcification that may contribute to their high cardiovascular …
Association of elevated serum PO4, Ca× PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients
Hyperphosphatemia is highly prevalent among patients with end-stage renal disease
(ESRD) and is associated with increased mortality risk in hemodialysis (HD) patients. The …
(ESRD) and is associated with increased mortality risk in hemodialysis (HD) patients. The …
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
C Schäfer, A Heiss, A Schwarz… - The Journal of …, 2003 - Am Soc Clin Investig
Ectopic calcification is a frequent complication of many degenerative diseases. Here we
identify the serum protein α2–Heremans-Schmid glycoprotein (Ahsg, also known as fetuin …
identify the serum protein α2–Heremans-Schmid glycoprotein (Ahsg, also known as fetuin …
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis
GA Block, KJ Martin, ALM De Francisco… - … England Journal of …, 2004 - Mass Medical Soc
Background Treatment of secondary hyperparathyroidism with vitamin D and calcium in
patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia …
patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia …
Vascular calcification: the killer of patients with chronic kidney disease
M Mizobuchi, D Towler… - Journal of the American …, 2009 - journals.lww.com
Cardiovascular complications are the leading cause of death in patients with chronic kidney
disease (CKD). Vascular calcification is a common complication in CKD, and investigators …
disease (CKD). Vascular calcification is a common complication in CKD, and investigators …
[HTML][HTML] Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in
patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces …
patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces …